Catalyst Health and Technology Partners is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow. The firm focuses on investment opportunities, including drug discovery, medical devices, biopharmaceuticals, drug delivery, convergence, and software.
CB Health Ventures LLC manages $150 million of private equity funds focused on investment opportunities in life sciences, medical devices, healthcare services, and medical information technology.
Founded in 2006, Vox Equity Partners, is a specialized private equity firm.
BioFrontier Partners, Inc. is a leading Japanese venture capital firm focused on life sciences with more than $100 million under management. Since its founding in 1999, BioFrontier Partners has invested in start-up companies in the following areas: biotechnology, pharmaceuticals, genomics, proteomics, agricultural biotechnology, natural products, medical devices, gene therapy, and drug discovery. BioFrontier Partners is headquartered in Tokyo and has a U.S. office in San Diego, CA.
Echelon Ventures seeks to maximize shareholder value by investing $1-5 million in credible, experienced management teams who are building a New England-based company that has developed and demonstrated proof-of-concept of a proprietary enabling technology.
Fletcher Spaght, Inc. provides strategy and financing assistance to new ventures, including start-up companies, risk capital investors, and emerging technologies/growth enterprises within larger organizations.
